UBS Group Begins Coverage on Stevanato Group (NYSE:STVN)

UBS Group assumed coverage on shares of Stevanato Group (NYSE:STVN) in a note issued to investors on Wednesday, Marketbeat Ratings reports. The firm set a “neutral” rating on the stock.

Several other research firms also recently issued reports on STVN. Wolfe Research assumed coverage on shares of Stevanato Group in a research note on Tuesday, June 2nd. They set an “outperform” rating and a $21.00 price target for the company. Weiss Ratings raised shares of Stevanato Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, August 27th. Finally, TD Cowen raised Stevanato Group to a “strong-buy” rating in a research report on Wednesday, June 17th. Two analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, Stevanato Group presently has an average rating of “Moderate Buy”.

Stevanato Group Stock Performance

Stevanato Group stock opened at €20.32 on Wednesday. The business has a 50 day moving average of €20.44 and a 200-day moving average of €17.76. Stevanato Group has a 1 year low of €12.89 and a 1 year high of €28.00. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.61 and a quick ratio of 1.08. The company has a market capitalization of $6.15 billion, a P/E ratio of 36.29, a P/E/G ratio of 1.63 and a beta of 0.75.

Stevanato Group (NYSE:STVN) last posted its earnings results on Wednesday, August 5th. The company reported €0.14 EPS for the quarter, missing the consensus estimate of €0.15 by (€0.01). Stevanato Group had a return on equity of 10.43% and a net margin of 10.99%.The business had revenue of €302.00 million for the quarter. On average, equities research analysts predict that Stevanato Group will post 0.71 earnings per share for the current year.

Insider Activity at Stevanato Group

In other news, Director Elisabetta Magistretti sold 2,045 shares of the firm’s stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of €20.09, for a total transaction of €41,084.05. Following the completion of the sale, the director owned 2,930 shares of the company’s stock, valued at €58,863.70. This trade represents a 41.11% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director William J. Federici sold 1,493 shares of the stock in a transaction on Monday, June 15th. The stock was sold at an average price of €17.09, for a total transaction of €25,515.37. Following the transaction, the director directly owned 26,991 shares in the company, valued at approximately €461,276.19. This represents a 5.24% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 14,249 shares of company stock worth $268,346 over the last quarter. 0.70% of the stock is owned by company insiders.

Institutional Trading of Stevanato Group

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. First Bank & Trust boosted its holdings in Stevanato Group by 3.4% in the second quarter. First Bank & Trust now owns 18,417 shares of the company’s stock worth $333,000 after acquiring an additional 603 shares in the last quarter. Fifth Third Bancorp lifted its holdings in shares of Stevanato Group by 22.6% in the 1st quarter. Fifth Third Bancorp now owns 4,196 shares of the company’s stock worth $58,000 after purchasing an additional 773 shares in the last quarter. GW&K Investment Management LLC lifted its holdings in shares of Stevanato Group by 76.2% in the 4th quarter. GW&K Investment Management LLC now owns 2,440 shares of the company’s stock worth $49,000 after purchasing an additional 1,055 shares in the last quarter. Pathstone Holdings LLC increased its stake in Stevanato Group by 1.5% during the 3rd quarter. Pathstone Holdings LLC now owns 71,178 shares of the company’s stock valued at $1,833,000 after purchasing an additional 1,067 shares in the last quarter. Finally, Mariner LLC increased its stake in Stevanato Group by 6.9% during the 3rd quarter. Mariner LLC now owns 25,447 shares of the company’s stock valued at $655,000 after purchasing an additional 1,638 shares in the last quarter.

Stevanato Group Company Profile

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.